Group 1 - The report focuses on advanced data collection technologies to ensure the accuracy, timeliness, and comprehensiveness of sales information, aiming to extract valuable industry trends and consumer insights from vast data for stakeholders in the pharmaceutical industry [6] - The data covers over 135,000 pharmacies nationwide, creating a large sample database that represents various regions, types, and scales of pharmacies, providing a broad basis for analysis [6] - The report successfully obtained information on 14 million prescription drug purchase orders, reflecting market dynamics and consumer demand [6] Group 2 - From January to November 2025, the order volume of prescription drugs in offline pharmacies showed a fluctuating upward trend, with the order index reaching 23.7 in November, indicating a strong growth momentum [9][19] - The distribution of orders varies significantly by province, with Guangdong, Sichuan, and Shandong leading in order share, while western provinces like Tibet and Qinghai have much lower shares, reflecting disparities in drug demand and healthcare resource allocation [24] - The order volume across provinces showed no significant fluctuations year-on-year, indicating a relatively stable market structure [25] Group 3 - In November 2025, the proportion of consumers aged 56 and above purchasing both Western and Chinese medicine slightly increased, with notable peaks in purchasing times for Western medicine around 10 AM and 7 PM, and for Chinese medicine around 11 AM [10][41] - The most common ailments among Western medicine consumers included influenza, particularly among those under 18, while Chinese medicine consumers primarily presented with Yin deficiency syndromes, showing significant differences across age groups and provinces [10][48] Group 4 - The report highlights that the purchasing preferences for specific drugs have shifted, with increased usage of Oseltamivir and Amlodipine in Western medicine, and rising popularity of Chinese herbs like Licorice and Goji Berries [11] - The sales rankings of various drugs differ significantly across provinces, with Fujian and Henan seeing increased sales of Oseltamivir and Cephalosporins, indicating regional variations in drug demand [11] Group 5 - The report provides a detailed analysis of consumer profiles, indicating an increase in the proportion of female consumers and those aged 56 and above in both Western and Chinese medicine purchases from November 2024 to November 2025 [35] - The report also notes that the purchasing behavior of consumers is influenced by their daily routines, with higher activity levels in the morning and evening, aligning with typical healthcare needs [41]

Group 1 - The report focuses on advanced data collection technologies to ensure the authenticity, timeliness, and comprehensiveness of sales information, aiming to extract valuable industry trends and consumer insights from vast data for stakeholders in the pharmaceutical industry [4][5] - The data covers over 135,000 pharmacies nationwide, creating a large sample database that represents various regions, types, and scales of pharmacies, providing a broad basis for analysis [4] - The report analyzes data from over 14 million prescription drug purchase orders, reflecting market dynamics and consumer demand [4] Group 2 - From January to November 2025, the order volume of prescription drugs in offline pharmacies showed a fluctuating upward trend, with the order index reaching 23.7 in November, indicating a strong growth momentum [5][14] - There are significant regional differences in order distribution, with provinces like Guangdong, Sichuan, and Shandong leading in order volume, while western provinces like Tibet and Qinghai have much lower shares, reflecting disparities in drug demand and healthcare resource allocation [5][20] Group 3 - In November 2025, the proportion of consumers aged 56 and above purchasing both Western and traditional Chinese medicine slightly increased, with female consumers also showing a slight rise [6][29] - The peak purchasing times for Western medicine are around 10 AM and 7 PM, while for traditional Chinese medicine, it peaks around 11 AM, indicating higher daytime purchasing activity [34] Group 4 - The report highlights that the proportion of consumers purchasing Western medicine for influenza significantly increased, particularly among the under-18 demographic, while traditional Chinese medicine consumers primarily presented with Yin deficiency syndromes [6][39] - The report identifies a rising trend in the use of specific Western medicines such as Oseltamivir and Amlodipine, with regional variations in popular products across provinces [7][20] Group 5 - The analysis of prescription drug consumers reveals that the proportion of consumers aged 56 and above has increased for both Western and traditional Chinese medicines, indicating a growing demand among older demographics [29][46] - The report provides insights into the disease patterns among different age groups, with influenza being the most prevalent among younger consumers, while chronic conditions like hypertension and diabetes are more common in older age groups [39][46] Group 6 - The report indicates that the disease composition among prescription drug consumers varies significantly by province and changes over time, with influenza and acute respiratory infections being common in regions like Chongqing and Guizhou, while hypertension is more prevalent in Sichuan [50][54] - The analysis of traditional Chinese medicine consumers shows that the most common syndromes include Yin deficiency and blood deficiency, reflecting diverse health concerns among consumers [57][71]